NRx Pharmaceuticals, Inc. (NRXP) ownership: Top institutional holder: B Group, Inc. ($6.39M). Insider activity: Net Seller (0 buys, 1 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| B Group, Inc. | 3000000.00 | $6.39M | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 1160184.00 | $2.47M | 2026-03-31 |
| VANGUARD GROUP INC | 729842.00 | $1.98M | 2025-12-31 |
| AdvisorShares Investments LLC | 420467.00 | $895595.00 | 2026-03-31 |
| COMMONWEALTH EQUITY SERVICES, LLC | 397431.00 | $846530.00 | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 310112.00 | $660609.00 | 2026-03-31 |
| RENAISSANCE TECHNOLOGIES LLC | 128175.00 | $422978.00 | 2025-09-30 |
| VANGUARD FIDUCIARY TRUST CO | 169580.00 | $361205.00 | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-01-27 |
Back to NRXP overview · NRXP earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.